Full Press Release Details
Significant progress
developing and identifying innovative hydrogel applications across consumer and medical uses culminating in December 2021 IPO
31, 2021, NEXGEL had approximately $13.3 Million cash to advance its programs as part of its growth strategy
PA. - January 10, 2022 - NEXGEL, Inc. ("NEXGEL" or the
"Company") (NASDAQ: NXGL, NXGLW), a manufacturer of high water content, electron beam cross-linked, aqueous polymer
hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetic, today is providing shareholders
with a 2021 year in review.
invested in its cGMP facility, established a strong executive team, and built a sales and marketing team as part of its efforts to become
a leading manufacturer of fully customizable, safe and consumer-friendly hydrogels that have the potential to address a wide range of
health, beauty and medical needs.
Business Segments and Growth Opportunities:
a successful 2021, I believe the future at Nexgel looks bright. The close of our IPO has provided us with sufficient cash to advance
our verticals for growth while continuing to invest in our manufacturing capabilities and product development," said Adam Levy,
and Financial Highlights:
shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state
or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities
laws of any such state or jurisdiction.
NEXGEL is a leading provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. Based in Langhorne,
PA., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. Alongside its strategic partners,
NEXGEL has formulated more than 200 different combinations to bring natural ingredients to gentle skin patches that can be worn for long
periods of time with little to no irritation.
Forward Looking Statements
contains certain forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve
known and unknown risks that are difficult to predict and include all matters that are not historical facts. In some cases, you can identify
forward-looking statements by the use of words such as "may," "could," "expect," "project,"
"outlook," "strategy," "intend," "plan," "seek," "anticipate,"
"believe," "estimate," "predict," "potential," "strive," "goal,"
"continue," "likely," "will," "would" and variations of these terms and similar expressions,
or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions
that, while considered reasonable by NEXGEL and its management, are inherently uncertain. The Company's actual results or developments
may differ materially from those projected or implied in these forward-looking statements. The Company's SEC filings are available
on the SEC's website at www.sec.gov. You should not place undue reliance on these forward-looking statements, which apply only
as of the date of this press release and should not be relied upon as representing the Company's views as of any subsequent date.
The Company explicitly disclaims any obligation to update any forward-looking statements, other than as may be required by law. If the
Company does update one or more forward-looking statements, no inference should be made that the Company will make additional updates
with respect to those or other forward-looking statements.
Valter Pinto / Nick Staab
KCSA Strategic Communications
212.896.1254 / 212.896.1254
KCSA Strategic Communications